Impaired tolerance in the International Immune Tolerance Induction study due to the presence of very low-titer inhibitors
Open Access
- 21 July 2025
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 23 (10) , 3124-3133
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- The Nijmegen ultra-sensitive Bethesda Assay detects very low-titer factor VIII inhibitors in patients with congenital and acquired hemophilia AThrombosis Research, 2023
- Hemophilia A with inhibitor: Immune tolerance induction (ITI) in the mirror of timeTransfusion and Apheresis Science, 2019
- Hemophilia A in the third millenniumBlood Reviews, 2013
- Immune tolerance induction in patients with hemophilia AThrombosis Research, 2011
- Impact of inhibitor epitope profile on the neutralizing effect against plasma‐derived and recombinant factor VIII concentrates in vitroHaemophilia, 2003
- The management of inhibitors in haemophilia A: introduction and systematic review of current practiceHaemophilia, 2003
- The epidemiology of inhibitors in haemophilia A: a systematic reviewHaemophilia, 2003
- Control of bleeding in patients with haemophilia A with inhibitors: a systematic reviewHaemophilia, 2003
- The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor developmentHaemophilia, 2001
- Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIIIThe Lancet, 1993